826

Shares

News site default image

93% of advanced leukemia patients in remission after immunotherapy

Shared by Radhika Narayanan | 654 158 14 | about 2 years ago

Twenty-seven of 29 patients with an advanced type of leukemia that had proved resistant to multiple other forms of therapy went into remission after their T cells (disease-fighting immune cells) were genetically engineered to fight their cancers. This study is the first CAR T-cell trial to infuse patients with an even mixture of two types of T cells (helper and killer cells, which work together to kill cancer).

Read More On www.sciencedaily.com

Categories Clinical research

Related Post

Links

https://www.sciencedaily.com/releases/2016/04/160427221202.htm
http://bit.ly/1rBQN3p

1 Votes

C

You must log in to post a comment

0 Comments